Alzheimer's disease therapeutic strategies

被引:0
作者
Alfredo, Sanabria-Castro [1 ]
Ileana, Alvarado-Echeverria [1 ]
Cecilia, Monge-Bonilla [1 ]
机构
[1] CCSS, Unidad Invest Hosp San Juan de Dios HSJD, San Jose, Costa Rica
来源
ENEUROBIOLOGIA | 2016年 / 7卷 / 15期
关键词
Alzheimer's disease; Cholinesterase inhibitors; Muscarinic receptors; Nicotinic receptors;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although Alzheimer's disease is the most common type of dementia currently there is no cure for it. Approved regulatory agencies therapeutic drugs limit to reduce specific symptoms and mildly improve the quality of life of patients. On this matter, the search for new therapeutic strategies has become a relevant necessity. This literature review briefly summarizes the main theories of the pathogenesis of Alzheimer's disease and addresses the main drugs that are used in the present. Other therapeutic strategies on study and substances commonly used are also discussed.
引用
收藏
页数:17
相关论文
共 103 条
[1]   Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function [J].
Albuquerque, Edson X. ;
Pereira, Edna F. R. ;
Alkondon, Manickavasagom ;
Rogers, Scott W. .
PHYSIOLOGICAL REVIEWS, 2009, 89 (01) :73-120
[2]   Citicoline in Vascular Cognitive Impairment and Vascular Dementia After Stroke [J].
Alvarez-Sabin, Jose ;
Roman, Gustavo C. .
STROKE, 2011, 42 (01) :S40-S43
[3]   The Genetics of Alzheimer's Disease [J].
Barber, Robert C. .
SCIENTIFICA, 2012, 2012
[4]   NSAID-derived γ-secretase modulators. Part III: Membrane anchoring [J].
Baumann, Stefanie ;
Hoettecke, Nicole ;
Schubenel, Robert ;
Baumann, Karlheinz ;
Schmidt, Boris .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (24) :6986-6990
[5]   The pharmacological management of Alzheimer's disease [J].
Bishara, Delia ;
Sauer, Justin ;
Taylor, David .
PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2015, 19 (04) :9-16
[6]   Small Molecule Protein-Protein Interaction Inhibitors as CNS Therapeutic Agents: Current Progress and Future Hurdles [J].
Blazer, Levi L. ;
Neubig, Richard R. .
NEUROPSYCHOPHARMACOLOGY, 2009, 34 (01) :126-141
[7]  
Burke A, 2015, POCKET REFERENCE ALZ, P33
[8]   M1 receptors play a central role in modulating AD-like pathology in transgenic mice [J].
Caccamo, A ;
Oddo, S ;
Billings, LM ;
Green, KN ;
Martinez-Coria, H ;
Fisher, A ;
LaFerla, FM .
NEURON, 2006, 49 (05) :671-682
[9]   γ-secretase as a therapeutic target for the treatment of Alzheimer's disease [J].
Churcher, I ;
Beher, D .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (26) :3363-3382
[10]   β-Secretase inhibition for the treatment of Alzheimer's disease -: promise and challenge [J].
Citron, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (02) :92-97